We are live on ! Find out more
MDGL icon

Madrigal Pharmaceuticals
MDGL

84 hedge funds and large institutions have $249M invested in Madrigal Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $11.1M | Put options by funds: $3.21M

Holders
84
Holders Change
+84
Holders Change %
–
% of All Funds
2.74%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
84
Increased
–
Reduced
–
Closed
–
Calls
$11.1M
Puts
$3.21M
Net Calls
+$7.93M
Net Calls Change
+$7.93M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Caxton Corporation
New Jersey
$118M +$176M +675,196 New
Jennison Associates
2
Jennison Associates
New York
$21.7M +$32.4M +124,111 New
PA
3
Perceptive Advisors
New York
$13.4M +$20.1M +76,950 New
QF
4
QVT Financial
New York
$12.1M +$18.1M +69,457 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$10.3M +$15.4M +59,109 New
SCA
6
SAC Capital Advisors
Connecticut
$10.1M +$15.1M +58,086 New
JP Morgan Chase
7
JP Morgan Chase
New York
$9.21M +$13.8M +52,746 New
BFA
8
BlackRock Fund Advisors
California
$8.33M +$12.4M +47,704 New
BBA
9
Baker Bros. Advisors
New York
$6.98M +$10.4M +39,973 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$5.25M +$7.84M +30,078 New
State Street
11
State Street
Massachusetts
$3.03M +$4.53M +17,382 New
Northern Trust
12
Northern Trust
Illinois
$2.97M +$4.43M +16,995 New
BIT
13
BlackRock Institutional Trust
California
$2.72M +$4.05M +15,551 New
NC
14
NBW Capital
Massachusetts
$2.04M +$3.04M +11,660 New
TCM
15
Tekla Capital Management
Massachusetts
$1.88M +$2.81M +10,764 New
Goldman Sachs
16
Goldman Sachs
New York
$1.76M +$2.63M +10,097 New
Jane Street
17
Jane Street
New York
$1.41M +$2.1M +8,066 New
CS
18
Credit Suisse
Switzerland
$1.27M +$1.9M +7,286 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$1.11M +$1.65M +6,334 New
SM
20
Sabby Management
Florida
$1.08M +$1.61M +6,179 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$915K +$1.37M +5,240 New
TCIM
22
TIAA CREF Investment Management
New York
$784K +$1.17M +4,490 New
SG Americas Securities
23
SG Americas Securities
New York
$781K +$1.17M +4,470 New
Morgan Stanley
24
Morgan Stanley
New York
$760K +$1.13M +4,349 New
MOACM
25
Mutual of America Capital Management
New York
$622K +$929K +3,563 New
1
2 3 4

MDGL Hedge Fund Activity: Q2 2013 in Review

84 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Madrigal Pharmaceuticals (MDGL) for Q2 2013, worth a combined $249M.

Buyers outnumbered sellers: 84 funds opened new MDGL positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.

  • 84 institutional investors held Madrigal Pharmaceuticals (MDGL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $249M of Madrigal Pharmaceuticals stock for Q2 2013.
  • 84 funds opened new Madrigal Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +84 holders.

Based on aggregated 13F filings for Q2 2013.